2022
DOI: 10.1016/j.arcmed.2022.02.001
|View full text |Cite
|
Sign up to set email alerts
|

Reduced Levels of Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Heart Failure with Reduced Ejection Fraction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
8
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 8 publications
(9 citation statements)
references
References 32 publications
1
8
0
Order By: Relevance
“…The flow cytometry analysis (FACS-Calibur flow cytometer, Becton Dickinson, San Jose, CA, USA) was performed two to three days after the blood collection. Staining and analysis were performed using a protocol adapted from Ahmed, et al [ 35 ], as previously reported [ 11 ]. For the quantitative assessment of circulating EPCs and CECs by flow cytometry, whole blood samples were incubated for 10 min with FcR-blocking reagent to block unwanted binding of antibodies to human Fc receptor-expressing cells.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The flow cytometry analysis (FACS-Calibur flow cytometer, Becton Dickinson, San Jose, CA, USA) was performed two to three days after the blood collection. Staining and analysis were performed using a protocol adapted from Ahmed, et al [ 35 ], as previously reported [ 11 ]. For the quantitative assessment of circulating EPCs and CECs by flow cytometry, whole blood samples were incubated for 10 min with FcR-blocking reagent to block unwanted binding of antibodies to human Fc receptor-expressing cells.…”
Section: Methodsmentioning
confidence: 99%
“…The number of EPCs is positively related to endothelial function [ 10 ] and has been used for the assessment of endothelial dysfunction [ 4 ]. Functionality and levels of EPCs are reduced in HF patients [ 11 , 12 ] and tend to decline with aging [ 13 ]. Indeed, reduced circulating levels of EPCs are related to increasing hazard ratios for all-cause mortality and cardiovascular death, independently of N-terminal pro B-type natriuretic peptide (NT-proBNP) levels [ 14 ], and circulating levels of EPCs are considered a strong and independent predictor of mortality in HF [ 15 , 16 ].…”
Section: Introductionmentioning
confidence: 99%
“…A possible explanation could be the already established extended vascular inflammation in HF, no matter of the myocardium’s function, and the increased number of inflammatory factors. EPCs are also shown to be significantly lower in HF compared to subjects without HF but with other cardiovascular risk factors, as well as to healthy subjects without cardiovascular risk factors [ 21 , 70 ]. The extended vascular inflammation in HF and the atherosclerotic process that leads to suppressed response in mobilization of progenitor cells from the bone marrow could explain these findings.…”
Section: Circulating Endothelial and Progenitor Cellsmentioning
confidence: 99%
“…They either transform in mature circulating endothelial cells (CECs) or remain as precursor cells restoring the dysfunctional and injured endothelium and promoting vasculogenesis and angiogenesis [ 19 , 20 ]. Recent studies have shown that circulating levels of EPCs and CECs are significantly decreased in HF patients with vascular endothelial dysfunction and inflammation compared to age-matched healthy subjects without established cardiovascular disease [ 21 ]. Thus, CECs and EPCs could be suggested as potential biomarkers of the cellular response to vascular injury in patients with HF [ 21 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation